XOMA Royalty (XOMA) Return on Invested Capital (2011 - 2026)

XOMA Royalty's (XOMA) quarterly Return on Invested Capital came in at 0.0% in Q1 2026, down 96.05% quarter-over-quarter from 0.0% in Q4 2025.

XOMA Royalty (XOMA) Return on Invested Capital (2011 - 2026) Analysis & Trends

XOMA Royalty has disclosed Return on Invested Capital across 11 years of filings, most recently posting 0.0% for Q1 2026.

  • Return on Invested Capital for Q1 2026 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, down 44.0% from the prior year.
  • Return on Invested Capital came in at 0.0% for Q1 2026 at XOMA Royalty, down from 0.0% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2025 to a low of 0.01% in Q2 2024.
  • The 3-year median for Return on Invested Capital is 0.0% (2025), against an average of 0.0%.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 0.01%
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -0.01%
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -0.01%
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 0.00%
9 Abivax 95.45 Bn 95.45 Bn - -
10 XOMA Royalty 5.52 Mn -60.56 Mn - 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2024 -0.01%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
Jun 30, 2021 0.00%
Mar 31, 2021 0.00%
Dec 31, 2020 0.00%
Sep 30, 2020 0.00%
Jun 30, 2020 0.00%
Mar 31, 2020 0.00%
Dec 31, 2018 -0.02%
Sep 30, 2018 -0.06%
Dec 31, 2017 0.01%
Sep 30, 2017 -0.13%
Sep 30, 2014 -0.19%
Jun 30, 2014 -0.05%
Mar 31, 2014 -0.05%
Dec 31, 2013 -0.08%